Optimizing Treatment for Major Depressive Disorder in Adolescents: The Impact of Intradermal Acupuncture - A Randomized Controlled Trial Protocol

Nisang Chen; Xiaoting Wu; Mingqi Tu; Sangsang Xiong; Junyan Jin; Siying Qu; Shuangyi Pei; Jianqiao Fang; Xiaomei Shao

doi:10.2147/NDT.S420489

Optimizing Treatment for Major Depressive Disorder in Adolescents: The Impact of Intradermal Acupuncture - A Randomized Controlled Trial Protocol

Neuropsychiatr Dis Treat. 2023 Aug 23:19:1819-1832. doi: 10.2147/NDT.S420489. eCollection 2023.

Authors

Nisang Chen^#¹, Xiaoting Wu^#¹, Mingqi Tu¹, Sangsang Xiong¹, Junyan Jin¹, Siying Qu¹, Shuangyi Pei^{1

2}, Jianqiao Fang^{1

2}, Xiaomei Shao^{1

2}

Affiliations

¹ Key Laboratory of Acupuncture and Neurology of Zhejiang Province, Department of Neurobiology and Acupuncture Research, The Third Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
² Key Laboratory for Research of Acupuncture Treatment and Transformation of Emotional Diseases, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.

^# Contributed equally.

Abstract

Background: Major depressive disorder (MDD) exhibits a pronounced occurrence among adolescents, aligning closely with the lifetime prevalence rate of 16.6% observed in adults. It is difficult to treat and prone to recurrence. Acupuncture has shown potential in enhancing treatment effectiveness. Nonetheless, there is a lack of research on the use of intradermal acupuncture (IA) in treating adolescent MDD.

Methods: This study is a double-blind, randomized controlled trial. A cohort of 120 participants will be assigned randomly to three distinct groups, namely a Selective Serotonin Reuptake Inhibitors (SSRIs)-only group, a sham intradermal acupuncture combined with SSRIs (SIA) group, and an active intradermal acupuncture combined with SSRIs (AIA) group. Hamilton Depression Rating Scale will serve as the primary outcome, while Patient Health Questionnaire-9, Self-Rating Depression Scale, Pittsburgh Sleep Quality Index, and Short Form 36 Questionnaire will serve as secondary outcomes in assessing the amelioration of depressive symptoms in patients. These data will be analyzed using SPSS26.0 software.

Results: We will assess the efficacy and safety of IA for MDD using commonly employed clinical psychiatric scales.

Conclusion: The efficacy of IA in treating adolescent MDD may be demonstrated in this study, suggesting its potential for optimizing MDD treatment schemes.

Trial registration: ClinicalTrials.gov Identifier: NCT05832619 (April 27, 2023).

Keywords: adolescent; intradermal acupuncture; major depressive disorder; protocol; randomized controlled trial; selective serotonin reuptake inhibitors.

Associated data

ClinicalTrials.gov/NCT05832619

Grants and funding

This work was funded by: Zhejiang Provincial TCM Science and Technology Program - Zhejiang Provincial TCM Modernization Special Project (2022ZX010).